Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury

[1]  Jan R. Detrez,et al.  Immune remodelling of stromal cell grafts in the central nervous system: therapeutic inflammation or (harmless) side‐effect? , 2017, Journal of tissue engineering and regenerative medicine.

[2]  Christopher K Salmon,et al.  Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease , 2016, Brain, Behavior, and Immunity.

[3]  H. Goossens,et al.  In Vivo Interleukin‐13‐Primed Macrophages Contribute to Reduced Alloantigen‐Specific T Cell Activation and Prolong Immunological Survival of Allogeneic Mesenchymal Stem Cell Implants , 2016, Stem cells.

[4]  S. Hendrix,et al.  Interleukin-25 is detrimental for recovery after spinal cord injury in mice , 2016, Journal of Neuroinflammation.

[5]  D. Voehringer,et al.  Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury , 2016, Journal of leukocyte biology.

[6]  S. Jeon,et al.  A Phase III Clinical Trial Showing Limited Efficacy of Autologous Mesenchymal Stem Cell Therapy for Spinal Cord Injury. , 2016, Neurosurgery.

[7]  T. Vangansewinkel,et al.  Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6 , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  F. C. Bennett,et al.  New tools for studying microglia in the mouse and human CNS , 2016, Proceedings of the National Academy of Sciences.

[9]  Leon E. Toussaint,et al.  Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model , 2016, Journal of Neuroinflammation.

[10]  T. Rőszer,et al.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms , 2015, Mediators of inflammation.

[11]  H. Goossens,et al.  Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain , 2014, Immunology and cell biology.

[12]  H. Weiner,et al.  Differential roles of microglia and monocytes in the inflamed central nervous system , 2014, The Journal of experimental medicine.

[13]  Š. Kubínová,et al.  Human Mesenchymal Stem Cells Modulate Inflammatory Cytokines after Spinal Cord Injury in Rat , 2014, International journal of molecular sciences.

[14]  P. Stinissen,et al.  Macrophage subsets and microglia in multiple sclerosis , 2014, Acta Neuropathologica.

[15]  Deborah S. Barkauskas,et al.  High-resolution intravital imaging reveals that blood-derived macrophages but not resident microglia facilitate secondary axonal dieback in traumatic spinal cord injury , 2014, Experimental Neurology.

[16]  T. Vangansewinkel,et al.  Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4 , 2014, Neurobiology of Disease.

[17]  A. Chalaris,et al.  ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in mice , 2013, Cell Death and Disease.

[18]  Liming Cheng,et al.  Genetic modification of mesenchymal stem cells in spinal cord injury repair strategies. , 2013, Bioscience trends.

[19]  A. Van der Linden,et al.  Tackling the physiological barriers for successful mesenchymal stem cell transplantation into the central nervous system , 2013, Stem Cell Research & Therapy.

[20]  R. Locksley,et al.  Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. , 2013, Annual review of immunology.

[21]  S. Hendrix,et al.  Mast cells protect from post‐traumatic brain inflammation by the mast cell‐specific chymase mouse mast cell protease‐4 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  H. Baba,et al.  Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. , 2012, Journal of neurotrauma.

[23]  I. Sung,et al.  Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. , 2012, Neurosurgery.

[24]  Percy A. Knolle,et al.  Living in the liver: hepatic infections , 2012, Nature Reviews Immunology.

[25]  R. Ransohoff,et al.  The Fractalkine Receptor but Not CCR2 Is Present on Microglia from Embryonic Development throughout Adulthood , 2012, The Journal of Immunology.

[26]  C. Brayton,et al.  Immunological Variation Between Inbred Laboratory Mouse Strains , 2012, Veterinary pathology.

[27]  M. Fehlings,et al.  Transplanted Neurally Modified Bone Marrow–Derived Mesenchymal Stem Cells Promote Tissue Protection and Locomotor Recovery in Spinal Cord Injured Rats , 2011, Neurorehabilitation and neural repair.

[28]  P. Popovich,et al.  Deficient CX3CR1 Signaling Promotes Recovery after Mouse Spinal Cord Injury by Limiting the Recruitment and Activation of Ly6Clo/iNOS+ Macrophages , 2011, The Journal of Neuroscience.

[29]  M. Höltje,et al.  C3 peptide enhances recovery from spinal cord injury by improved regenerative growth of descending fiber tracts , 2010, Journal of Cell Science.

[30]  G. Bernardi,et al.  Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. , 2010, Current medicinal chemistry.

[31]  K. Horn,et al.  Overcoming Macrophage-Mediated Axonal Dieback Following CNS Injury , 2009, The Journal of Neuroscience.

[32]  C. Colton.  Heterogeneity of Microglial Activation in the Innate Immune Response in the Brain , 2009, Journal of Neuroimmune Pharmacology.

[33]  Michal Schwartz,et al.  The bright side of the glial scar in CNS repair , 2009, Nature Reviews Neuroscience.

[34]  K. Horn,et al.  Another Barrier to Regeneration in the CNS: Activated Macrophages Induce Extensive Retraction of Dystrophic Axons through Direct Physical Interactions , 2008, The Journal of Neuroscience.

[35]  Irina A. Kochetkova,et al.  IL-13 Production by Regulatory T Cells Protects against Experimental Autoimmune Encephalomyelitis Independently of Autoantigen1 , 2008, The Journal of Immunology.

[36]  R. Nitsch,et al.  The role of T helper cells in neuroprotection and regeneration , 2007, Journal of Neuroimmunology.

[37]  Seung U. Kim,et al.  Interleukin-13 Enhances Cyclooxygenase-2 Expression in Activated Rat Brain Microglia: Implications for Death of Activated Microglia1 , 2006, The Journal of Immunology.

[38]  Aileen J Anderson,et al.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. , 2006, Journal of neurotrauma.

[39]  G. Martino,et al.  The therapeutic potential of neural stem cells , 2006, Nature Reviews Neuroscience.

[40]  A. Vandenbark,et al.  Treatment of Passive Experimental Autoimmune Encephalomyelitis in SJL Mice with a Recombinant TCR Ligand Induces IL-13 and Prevents Axonal Injury1 , 2005, The Journal of Immunology.

[41]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[42]  David L. Lacey,et al.  Osteoclast differentiation and activation , 2003, Nature.

[43]  S. Barger,et al.  Pro‐inflammatory and pro‐oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17β‐estradiol , 2001, Journal of neurochemistry.

[44]  Kristi Kincaid,et al.  M-1/M-2 Macrophages and the Th1/Th2 Paradigm1 , 2000, The Journal of Immunology.

[45]  B. Gesser,et al.  Regulation of human T lymphocyte chemotaxis in vitro by T cell-derived cytokines IL-2, IFN-gamma, IL-4, IL-10, and IL-13. , 1995, Journal of immunology.

[46]  A. Minty,et al.  Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. , 1994, Journal of immunology.

[47]  S. Gordon,et al.  Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γ , 1994, European journal of immunology.

[48]  R. Coffman,et al.  Modulation of murine macrophage function by IL-13. , 1993, Journal of immunology.

[49]  S. Hendrix,et al.  Immunopharmacological intervention for successful neural stem cell therapy: New perspectives in CNS neurogenesis and repair. , 2014, Pharmacology & therapeutics.

[50]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.